EA201790795A1 - СОЕДИНЕНИЯ 4Н-ПИРИДО[1,2-a]ПИРИМИДИН-4-ОНА - Google Patents

СОЕДИНЕНИЯ 4Н-ПИРИДО[1,2-a]ПИРИМИДИН-4-ОНА

Info

Publication number
EA201790795A1
EA201790795A1 EA201790795A EA201790795A EA201790795A1 EA 201790795 A1 EA201790795 A1 EA 201790795A1 EA 201790795 A EA201790795 A EA 201790795A EA 201790795 A EA201790795 A EA 201790795A EA 201790795 A1 EA201790795 A1 EA 201790795A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
pyrido
pyrimidin
compositions
formula
Prior art date
Application number
EA201790795A
Other languages
English (en)
Other versions
EA031505B1 (ru
Inventor
Пенелопа Джейн Хаггинс
Джек Гордон Парсонс
Кевин Джеффри Барнхем
Элизабет Колет Луиза Готье
Энтони Винсент Робинсон
Original Assignee
Прана Байотекнолоджи Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014904868A external-priority patent/AU2014904868A0/en
Application filed by Прана Байотекнолоджи Лимитед filed Critical Прана Байотекнолоджи Лимитед
Publication of EA201790795A1 publication Critical patent/EA201790795A1/ru
Publication of EA031505B1 publication Critical patent/EA031505B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/06—Zinc compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее изобретение относится к соединениям формулы I или II, способам их получения и их применению в качестве фармацевтических агентов или композиций для лечения неврологических расстройств.
EA201790795A 2014-12-02 2015-12-02 СОЕДИНЕНИЯ 4Н-ПИРИДО[1,2-а]ПИРИМИДИН-4-ОНА EA031505B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2014904868A AU2014904868A0 (en) 2014-12-02 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
PCT/AU2015/000730 WO2016086261A1 (en) 2014-12-02 2015-12-02 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS

Publications (2)

Publication Number Publication Date
EA201790795A1 true EA201790795A1 (ru) 2017-07-31
EA031505B1 EA031505B1 (ru) 2019-01-31

Family

ID=56090727

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790795A EA031505B1 (ru) 2014-12-02 2015-12-02 СОЕДИНЕНИЯ 4Н-ПИРИДО[1,2-а]ПИРИМИДИН-4-ОНА

Country Status (10)

Country Link
US (4) US10287285B2 (ru)
EP (1) EP3227292B1 (ru)
JP (2) JP6784942B2 (ru)
KR (1) KR20170088851A (ru)
CN (2) CN107001360B (ru)
AU (2) AU2015358284B2 (ru)
BR (1) BR112017011335A2 (ru)
CA (1) CA2968090A1 (ru)
EA (1) EA031505B1 (ru)
WO (1) WO2016086261A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017040879A1 (en) * 2015-09-04 2017-03-09 Lysosomal Therapeutics Inc. Thiazolo(3,2-a) pyrimidinone and other heterobicyclic pyrimidinone compounds for use in medical therapy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022897A (en) * 1974-03-04 1977-05-10 E. R. Squibb & Sons, Inc. CNS active compounds
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
HU178910B (en) * 1977-08-19 1982-07-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
AU2002951868A0 (en) * 2002-10-04 2002-10-24 Prana Biotechnology Limited Compound i
NZ539211A (en) * 2002-10-04 2008-05-30 Prana Biotechnology Ltd Neurologically-active compounds
AR053358A1 (es) 2005-04-15 2007-05-02 Cancer Rec Tech Ltd Inhibidores de adn - pk
CA2683756A1 (en) * 2006-04-14 2007-10-25 Prana Biotechnology Limited Method of treatment of age-related macular degeneration(amd)
US8163760B2 (en) * 2006-06-22 2012-04-24 Prana Biotechnology Limited Use of pyridopyrimidine compounds in the treatment of gliomas
US8785452B2 (en) * 2008-06-17 2014-07-22 Institut National De La Sante Et De La Recherche Medicale Anti-infective compounds
EP2157433A1 (en) 2008-08-18 2010-02-24 Centre National De La Recherche Scientifique (Cnrs) New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
WO2010136778A1 (en) * 2009-05-29 2010-12-02 Kudos Pharmaceuticals Limited Dibenzothiophene derivatives as dna- pk inhibitors
CN102812023A (zh) * 2010-01-13 2012-12-05 韩国巴斯德研究所 抗感染吡啶并(1,2-a)嘧啶类

Also Published As

Publication number Publication date
US20170267676A1 (en) 2017-09-21
CN107001360A (zh) 2017-08-01
AU2015358284A1 (en) 2017-06-15
WO2016086261A1 (en) 2016-06-09
US20190352301A1 (en) 2019-11-21
JP2017537108A (ja) 2017-12-14
KR20170088851A (ko) 2017-08-02
US10287285B2 (en) 2019-05-14
CN111961050A (zh) 2020-11-20
AU2020239797A1 (en) 2020-10-29
CN107001360B (zh) 2020-09-18
JP2021011492A (ja) 2021-02-04
AU2015358284B2 (en) 2020-07-02
US10738050B2 (en) 2020-08-11
US20200317670A1 (en) 2020-10-08
EP3227292B1 (en) 2022-03-09
JP6784942B2 (ja) 2020-11-18
EP3227292A1 (en) 2017-10-11
BR112017011335A2 (pt) 2018-02-20
EA031505B1 (ru) 2019-01-31
US20210230159A1 (en) 2021-07-29
CA2968090A1 (en) 2016-06-09
US11008319B2 (en) 2021-05-18
EP3227292A4 (en) 2018-06-13

Similar Documents

Publication Publication Date Title
EA201990657A1 (ru) Соединения и композиции в качестве ингибиторов эндосомальных toll-подобных рецепторов
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
PH12016501898A1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
EA201692177A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
PH12016501570A1 (en) Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists
EA201792047A1 (ru) Новые соединения
MX2018000396A (es) Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4).
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
EA201790273A1 (ru) Флагеллиновые композиции и их применение
MY192717A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
EA201990240A1 (ru) Новые трициклические соединения в качестве противораковых средств
UY36056A (es) “compuestos de heteroarilo o arilo bicíclicos fusionados “.
TR201901886T4 (tr) DNA-PK inhibitörleri.
PH12017500401A1 (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
EA201890449A1 (ru) Фумагиллиновые гетероциклические соединения и способы их получения и применения
EA201790949A1 (ru) Замещенные 2,4-диаминохинолины в качестве новых противораковых средств
EA201691674A1 (ru) 1,2-замещенные циклопентаны в качестве антагонистов рецептора орексина
EA201990400A1 (ru) Соединения и композиции и их применение
EA201491520A1 (ru) НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ C-met ПРОТЕИНКИНАЗ
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
EA201891710A1 (ru) Терапевтические соединения
WO2014035846A3 (en) Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
EA201791432A1 (ru) Композиции на основе пролекарства монометилфумарата